Therapy News and Research

RSS

Innovative combination of treatments effectively kills acute myeloid leukemia cells

Scientists at VCU Massey Comprehensive Cancer Center have identified an innovative combination of treatment strategies that work collaboratively to effectively kill acute myeloid leukemia (AML) cells, a frequently incurable form of cancer.

27 Feb 2025

Breast-conserving therapy linked to better sexual well-being compared to mastectomy

For women with breast cancer, breast-conserving therapy (BCT) is associated with improved sexual well-being, compared to mastectomy followed by breast reconstruction, reports a study in the March issue of Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons (ASPS).

26 Feb 2025

Corticosteroid use linked to higher risk of lupus pericarditis recurrence

A new study of more than 2,900 patients provides evidence that it's likely best to use as little corticosteroid medicine as possible when treating people who have lupus pericarditis, a common heart complication of the autoimmune disease Systemic Lupus Erythematosus (SLE).

26 Feb 2025

UCLA scientists discover new approach for treating glioblastoma

UCLA scientists have identified a potential new strategy for treating glioblastoma, the deadliest form of brain cancer, by reprogramming aggressive cancer cells into harmless ones.

26 Feb 2025

Anti-swelling drug may weaken immune system in brain cancer patients

Swelling caused by brain cancer is a serious problem that can lead to serious side effects and even death. While controlling swelling is important, a new study shows that a commonly prescribed anti-swelling drug suppresses the immune system for weeks after dosage, inhibiting the body's ability to fight the cancer.

26 Feb 2025

Scientists pioneer fecal transplant capsules to enhance pancreatic cancer treatment

Scientists at Lawson Research Institute (Lawson) of St. Joseph's Health Care London and London Health Sciences Centre Research Institute (LHSCRI) are the first in the world to study fecal transplants using capsules containing microbes from the gut of healthy volunteers to improve the response of patients with advanced pancreatic cancer to chemotherapy.

26 Feb 2025

Exploring the role of SNPs in early diagnosis of coronary microvascular dysfunction

A new review highlights the potential role of single nucleotide polymorphisms (SNPs) in improving the early diagnosis and targeted intervention of coronary microvascular dysfunction (CMD)—a condition linked to myocardial ischemia despite the absence of major artery blockages.

26 Feb 2025

Tardigrade protein offers radiation protection for cancer patients

About 60 percent of all cancer patients in the United States receive radiation therapy as part of their treatment.

26 Feb 2025

Microphysiological systems in drug discovery

NewsMedical speaks with CN Bio about the translatability between in vitro organ-on-a-chip (OOC) models, microphysiological systems, and their in vivo counterparts.

From CN Bio 26 Feb 2025

New low-cost tool could revolutionize type 2 diabetes treatment

Millions of people with type 2 diabetes could receive better treatment thanks to a new, simple low-cost tool, according to groundbreaking research announced today at the Diabetes UK Professional Conference 2025 and published in the Lancet.

26 Feb 2025

Sphere Fluidics rebrands to Sphere Bio

Sphere Fluidics today announced its rebranding to Sphere Bio. The name change marks a significant milestone in the Company’s development, reflecting its transition from a leading droplet-based microfluidics innovator to an established commercial provider of integrated life sciences tools and solutions.

From Fluidic Sciences and Sphere Bio 26 Feb 2025

New antibody-toxin conjugate designed to stimulate immune-mediated eradication of tumors

Researchers at The University of Texas MD Anderson Cancer Center have developed a novel antibody-toxin conjugate (ATC) designed to stimulate immune-mediated eradication of tumors.

25 Feb 2025

Cooling treatment shows no benefits for preterm infants with hypoxic ischemic encephalopathy

Lowering the body temperature of preterm infants (born at 33 to 35 weeks of pregnancy) with hypoxic ischemic encephalopathy (HIE)-a type of brain damage caused by oxygen loss-offers no benefits over standard care, according to a study funded by the National Institutes of Health (NIH).

25 Feb 2025

New research reveals how cell state affects leukemia progression

Myeloid leukaemias are among the most aggressive blood cancers and have low survival rates. Today, leukaemia patients undergo genetic analysis to identify mutations and select the most appropriate treatment.

25 Feb 2025

New mechanism uncovered to combat therapy-resistant cancer cells

One particular challenge in the treatment of cancer is therapy resistance. An international research team has now discovered a mechanism that opens up new treatment strategies for tumors in which conventional chemotherapeutic agents have reached their limits.

25 Feb 2025

Morning blue light therapy enhances sleep quality for seniors

Blue-enriched light can improve sleep quality and daily activity in older adults living at home, according to new research from the University of Surrey.

25 Feb 2025

UCL researchers develop groundbreaking therapy for a common cause of high blood pressure

A minimally invasive therapy that has the potential to transform treatment of a common cause of high blood pressure, has been developed by researchers at UCL, Queen Mary University of London and Barts Health.

25 Feb 2025

Scientists aim to regenerate lungs for premature infants with BPD

Understanding resilience - the ability of injured lung tissue to heal and regenerate - may be key to advancing the treatment and prevention of life-threatening lung disease that occurs in extremely premature babies, a new study suggests.

25 Feb 2025

Higher 'bad' cholesterol levels may help Sardinia’s seniors live longer, study finds

Higher LDL cholesterol levels (≥130 mg/dL) were linked to longer survival in Sardinian nonagenarians, challenging the conventional belief that lower cholesterol is always better. However, very high cholesterol levels, particularly in women, did not show additional longevity benefits.

24 Feb 2025

FDA-approved technology offers personalized treatment for Parkinson’s symptoms

Starting today, people with Parkinson's disease will have a new treatment option, thanks to U.S. Food and Drug Administration approval of groundbreaking new technology.

24 Feb 2025

Therapy News and Research

Innovative combination of treatments effectively kills acute myeloid leukemia cells

Breast-conserving therapy linked to better sexual well-being compared to mastectomy

Corticosteroid use linked to higher risk of lupus pericarditis recurrence

UCLA scientists discover new approach for treating glioblastoma

Anti-swelling drug may weaken immune system in brain cancer patients

Scientists pioneer fecal transplant capsules to enhance pancreatic cancer treatment

Exploring the role of SNPs in early diagnosis of coronary microvascular dysfunction

Tardigrade protein offers radiation protection for cancer patients

Microphysiological systems in drug discovery

New low-cost tool could revolutionize type 2 diabetes treatment

Sphere Fluidics rebrands to Sphere Bio

New antibody-toxin conjugate designed to stimulate immune-mediated eradication of tumors

Cooling treatment shows no benefits for preterm infants with hypoxic ischemic encephalopathy

New research reveals how cell state affects leukemia progression

New mechanism uncovered to combat therapy-resistant cancer cells

Morning blue light therapy enhances sleep quality for seniors

UCL researchers develop groundbreaking therapy for a common cause of high blood pressure

Scientists aim to regenerate lungs for premature infants with BPD

Higher 'bad' cholesterol levels may help Sardinia’s seniors live longer, study finds

FDA-approved technology offers personalized treatment for Parkinson’s symptoms

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News